MedVellum
MedVellum
Back to Library
Paediatrics
Dermatology
General Practice

Molluscum Contagiosum (Child)

High EvidenceUpdated: 2025-12-25

On This Page

Red Flags

  • Extensive Lesions in Immunocompromised
  • Giant Molluscum (Suggests HIV)
  • Secondary Bacterial Infection
Overview

Molluscum Contagiosum (Child)

1. Clinical Overview

Summary

Molluscum contagiosum is a Common, Benign, Self-Limiting Viral Skin Infection caused by the Molluscum Contagiosum Virus (MCV), a member of the Poxviridae family. It is characterised by Discrete, Dome-Shaped, Umbilicated Papules with a central dimple (Umbilication) containing a white, waxy core. The condition is extremely common in Children aged 1-10 years, spread by Direct Skin-to-Skin Contact, Autoinoculation, and Fomites. Lesions typically appear on the Face, Trunk, Axillae, and Limbs in children. In Immunocompetent patients, molluscum is Self-Limiting, resolving spontaneously within 6-18 months (Sometimes up to 2-4 years) without scarring. Treatment is often Unnecessary but may be considered for cosmetic reasons, To prevent spread, Or if lesions are symptomatic. Options include Physical Destruction (Cryotherapy, Curettage), Topical Agents (Potassium Hydroxide, Imiquimod), and Watchful Waiting (Preferred). In Immunocompromised patients (HIV/AIDS), molluscum can be extensive, Giant, And recalcitrant, serving as a marker of disease. [1,2,3]

Key Facts

FactValue
DefinitionViral skin infection with umbilicated papules
Causative AgentMolluscum Contagiosum Virus (MCV), Poxviridae
Peak Age1-10 years
TransmissionDirect contact, Autoinoculation, Fomites
Incubation2-6 weeks (Up to 6 months)
Duration (Untreated)6-18 months (Range 6 months - 4 years)
DiagnosisClinical (Characteristic appearance)
TreatmentWatchful waiting (First-line)

Clinical Pearls

"Umbilicated Papules with Central Dimple": Pathognomonic appearance.

"Leave Them Alone": Self-limiting in immunocompetent. Watch and wait is first-line.

"BOTE Sign": Beginning Of The End – Inflammatory reaction around lesions signals immune clearance.

"Extensive or Giant Molluscum = Consider Immunodeficiency": Screen for HIV if appropriate.

"Molluscum Dermatitis": Eczematous reaction around lesions – Treat with emollients/Mild TCS.

Why This Matters Clinically

Molluscum contagiosum is one of the most common viral skin infections in children and a frequent presentation in primary care and paediatric dermatology. Although benign and self-limiting, it causes significant parental anxiety and school exclusion debates. Understanding the natural history is essential to avoid unnecessary, Potentially scarring interventions. Recognition of atypical or extensive molluscum is important as it may indicate underlying immunodeficiency. This condition is commonly examined due to its characteristic clinical appearance and management decision-making.


2. Epidemiology

Global Burden

MetricDataNotes
Worldwide Prevalence2-10% of childrenHigher in tropical regions
Peak Prevalence Age1-10 yearsImmune-naive population
Annual Incidence0.1-0.5% in developed countriesHigher in developing regions
Consultation Rate5-10% of paediatric dermatology referralsCommon reason for consultation
Economic BurdenSignificantParental anxiety, Unnecessary treatments, School exclusion debates

Incidence & Prevalence by Age

Age GroupPrevalenceNotes
Infants (less than 1 year)Less than 1%Rare, Maternal antibodies may provide protection
Toddlers (1-3 years)3-5%Increasing with daycare exposure
Preschool (3-5 years)5-8%Peak onset age
School Age (5-10 years)5-10%Peak prevalence
Adolescents (10-18 years)2-4%Decreasing, Prior immunity
Adults1-2%Often sexually transmitted in this age group

Geographic Distribution

RegionPrevalenceFactors
Tropical/SubtropicalHigher (Up to 15%)Heat, Humidity, Skin exposure, Overcrowding
Temperate DevelopedLower (2-8%)Better hygiene, Less crowding
Sub-Saharan AfricaVery High (Up to 20%)HIV epidemic, Overcrowding
Asia-PacificModerate-HighVariable by country
Middle EastModerateTraditional dress may reduce skin contact

Demographics

FactorDetailsClinical Significance
AgePeak 1-10 years, Median onset 5 yearsImmune naïve to MCV
SexEqual male:female ratioNo sex predilection
EthnicityAll ethnicities affected equallyNo racial predilection
SocioeconomicMay be higher in lower SES (Overcrowding)Increased contact transmission
SettingDaycare, Schools, Swimming pools, SportsClose contact environments

Transmission Patterns

ModeContributionDetails
Direct Skin-to-Skin ContactPrimary (60-70%)Play, Wrestling, Contact sports, Bathing together
AutoinoculationMajor (Secondary spread)Scratching spreads to new sites on same child
FomitesModerate (20-30%)Towels, Clothing, Bath toys, Gym equipment
Swimming PoolsDebated (Low-Moderate)May be pool surroundings rather than water itself
Sexual TransmissionAdultsGenital MC in adults typically sexually transmitted

Transmission Settings

SettingRisk LevelPrevention
Household/SiblingsHighAvoid sharing towels, Separate bathing
Daycare/NurseryModerate-HighGeneral hygiene, Cover lesions
Swimming PoolsLow-ModerateCover lesions (Optional), Not mandatory exclusion
Contact SportsModerateCover lesions during activity
SchoolsLowNo exclusion required

Risk Factors for Acquisition

FactorRelative RiskMechanism
Young Age (1-10 years)High (Baseline)Immune naïve to MCV
Atopic Dermatitis/EczemaRR 3-4Impaired skin barrier, Xerosis, Increased scratching
Immunodeficiency (HIV)Very HighImpaired T-cell immunity
Close Household ContactRR 2-3Direct transmission opportunity
Sibling with MCRR 2-4Prolonged close contact
Swimming Pool UseRR 1.5-2 (Debated)Fomite/Contact spread in changing areas
Shared BathingModerateDirect contact, Fomites
Daycare AttendanceModerateMultiple contacts
OvercrowdingModerateIncreased contact opportunity

Risk Factors for Extensive or Prolonged Disease

FactorNotesManagement Implication
HIV/AIDSGiant molluscum, 100s of lesions, RecalcitrantTest for HIV if extensive. Optimise ART.
Primary ImmunodeficiencyT-cell defects (SCID, DiGeorge)Immunology referral. Aggressive treatment.
Immunosuppressive TherapyTransplant, Chemotherapy, BiologicsReduce immunosuppression if possible. Treat lesions.
Atopic DermatitisMore lesions, Longer durationTreat eczema. Emollients.
Extensive ScratchingAutoinoculation spreads diseaseDiscourage scratching. Trim nails.

Seasonal Variation

SeasonIncidencePossible Reasons
SummerHigherMore skin exposure, Swimming, Increased contact
WinterLowerMore clothing, Less direct contact
School YearModerateIncreased contact in settings
HolidaysMay increaseSwimming, Camps, Family contact

3. Pathophysiology

Virology

FeatureDetails
VirusMolluscum Contagiosum Virus (MCV)
FamilyPoxviridae
SubtypesMCV-1 (Most common, Children), MCV-2 (Adults, Sexually transmitted)
GenomeDouble-stranded DNA
HostHumans only
TargetKeratinocytes of epidermis

Mechanism

Step 1: Viral Entry and Infection

  • Transmission: Direct skin-to-skin contact, Autoinoculation (Scratching), Fomites
  • Entry: Virus enters through minor breaks in epidermis
  • Target Cells: Basal keratinocytes
  • No Viraemia: Infection remains localised to epidermis

Step 2: Viral Replication

  • Incubation: 2-6 weeks (Can be up to 6 months)
  • Replication: Virus replicates in keratinocyte cytoplasm
  • Henderson-Patterson Bodies: Inclusion bodies (Molluscum bodies) – Aggregates of viral particles in cytoplasm
  • No incorporation into host DNA

Step 3: Lesion Development

  • Hyperplasia: Infected keratinocytes proliferate
  • Lobulated Growth: Epidermis extends into dermis
  • Central Core: Keratinocytes filled with viral particles (White cheesy material)
  • Umbilication: Central dimple forms as superficial cells shed

Step 4: Immune Evasion

  • Localised Infection: No systemic spread
  • Immune Evasion Proteins: MCV produces proteins that inhibit inflammatory response
  • Delayed Recognition: Virus "hides" from immune system
  • Explains prolonged course: Months to years before clearance

Step 5: Immune Clearance (BOTE Sign)

  • Cell-Mediated Immunity: Eventually recognises infection
  • Inflammatory Response: Lesions become red, Swollen, Tender
  • "Beginning Of The End" (BOTE): Inflammation signals immune clearance
  • Resolution: Lesions resolve, Usually without scarring
  • Post-Inflammatory Changes: Temporary hypopigmentation/Hyperpigmentation possible

Histology

FindingDescription
Molluscum Bodies (Henderson-Patterson Bodies)Large eosinophilic intracytoplasmic inclusion bodies. Pathognomonic.
Epidermal HyperplasiaLobulated proliferation extending into dermis
Central CraterContains keratinised debris and virus
Minimal InflammationUntil resolution phase

4. Clinical Presentation

Overview of Presentation

AspectDetails
Typical PatientChild aged 2-8 years with clusters of small papules
OnsetGradual, Often unnoticed initially
CourseWaxing and waning over months
ResolutionSpontaneous, Usually within 6-18 months
Parental ConcernCommon, Often disproportionate to severity

Lesion Morphology - Detailed

FeatureDescriptionDistinguishing Points
ShapeDome-shaped, Hemispherical papulesRounded, Not flat-topped
Size1-5mm typicallyUp to 10-15mm = Giant molluscum (Red flag)
SurfaceSmooth, Shiny, WaxyUnlike warts which are rough
ColourFlesh-coloured, Pink, White, PearlyMay have slight translucency
UmbilicationCentral dimple (Pathognomonic)May need magnification or dermoscopy to see
CoreWhite, Cheesy, Waxy material expressibleMolluscum body - contains viral particles
NumberFew to hundreds. Average 10-20.Extensive = Consider immunodeficiency
GroupingOften clusteredAutoinoculation creates satellite lesions
BaseNon-erythematous (Unless BOTE or infected)Erythema suggests inflammation

Severity Staging

StageNumber of LesionsDescriptionManagement Approach
Minimal1-5Few isolated lesionsWatchful waiting
Mild6-20Scattered lesions, Limited areasWatchful waiting OR treat if requested
Moderate21-50Multiple areas involvedConsider treatment if distressing
Extensive51-100Widespread involvementConsider immunodeficiency. May warrant treatment.
SevereGreater than 100Very extensive, May be confluentInvestigate immunodeficiency. Specialist referral.

Distribution Patterns

Common Distribution (Children):

SiteFrequencyNotes
FaceVery Common (30-40%)Especially periocular, Cheeks
EyelidsCommonMay cause chronic conjunctivitis
TrunkVery Common (40-50%)Chest, Abdomen, Back
AxillaeCommonIntertriginous area
Antecubital FossaeCommonFlexural predilection
Popliteal FossaeCommonBehind knees
Upper ArmsCommonAccessible to scratching
ThighsModerateInner thighs especially
Genital Area (Children)5-10%Non-sexual transmission via bathing, Contact
ButtocksModerateBathing/Sitting transmission

Distribution in Adults:

SiteNotes
Genital/PerigenitalPredominant in sexually transmitted cases
Lower Abdomen
Inner Thighs
Face (Adults + HIV)May be extensive with HIV

Symptom Analysis

SymptomFrequencySeverityNotes
Asymptomatic70-80%NoneMost children have no symptoms from lesions
Mild Pruritus15-20%MildEspecially with associated eczema
Cosmetic ConcernVery CommonVariableParental anxiety common
PainRareMinimalOnly with secondary infection
Tenderness10%MildEspecially during BOTE phase
Secondary Infection Symptoms5-10%Mild-ModerateErythema, Warmth, Pustules, Crusting

Timeline and Evolution

PhaseDurationClinical Features
Incubation2-6 weeks (Up to 6 months)No visible lesions
Early/New LesionsWeeksSmall, May lack obvious umbilication
Established LesionsMonthsClassic dome-shaped, Umbilicated appearance
Autoinoculation PhaseVariableNumber may increase if scratched
BOTE Phase1-4 weeksLesions become inflamed, Red, Tender
Resolution1-4 weeks per lesionLesions shrink and disappear
Post-InflammatoryWeeks-MonthsTemporary pigment changes possible

Associated Features - Detailed

FeatureIncidenceDescriptionManagement
Molluscum Dermatitis10-30%Eczematous/Erythematous reaction around lesions. Immune response, Not infection. Pruritic.Emollients, Mild topical corticosteroids (HC 1%)
Eczema MolluscatumVariableSuperimposed eczema herpeticum-like appearanceMay mimic bacterial infection. Ensure not truly infected.
KoebnerisationCommonNew lesions appearing along sites of trauma (scratches)Discourage scratching
BOTE SignPrecedes resolutionInflamed, Red, Swollen, Tender lesionsReassure. This signals resolution. No treatment needed.
Satellite LesionsCommonClustering around original lesionsResult of autoinoculation

Age-Related Variations

Age GroupTypical Features
Toddlers (1-3 years)Few lesions, May increase, Often facial
Preschool (3-5 years)More lesions, Trunk/limbs, May spread in daycare
School Age (5-10 years)Most common presentation, Variable severity
AdolescentsLess common, May have genital lesions
AdultsGenital predominant (STI), Or extensive if immunocompromised

Atypical Presentations - Expanded

PresentationIncidenceContextAction
Giant Molluscum (greater than 1cm)RareImmunocompromised, HIVTest for HIV if risk. Optimise immunity.
Extensive (greater than 50-100 lesions)5-10%Immunocompromised, Atopic dermatitisScreen for immunodeficiency
Facial/Eyelid Predominant20-30%Normal variant in childrenMay need treatment if causing conjunctivitis
Inflamed LesionsCommonBOTE (Resolving) OR Secondary infectionDifferentiate: BOTE = Red, Tender. Infection = Pustules, Spread.
Genital in PrepubescentTo considerUsually non-sexual (bathing, contact)Consider but do not assume abuse. Context important.
Unilateral DistributionOccasionalMay follow lymphatic drainageCheck not zosteriform distribution (HSV)
PedunculatedRareStalk-like attachmentMay be confused with skin tag
EczematousWith underlying ADExtensive, Pruritic, Surrounded by dermatitisTreat eczema aggressively

Red Flags - Detailed

[!CAUTION] Red Flags – Investigate for Immunodeficiency:

  • Giant molluscum (greater than 1cm diameter)
  • Extensive disease (greater than 50-100 lesions)
  • Recalcitrant, Not resolving after 2-4 years
  • Atypical sites or distribution
  • Associated with other opportunistic infections
  • Adult with extensive facial lesions
  • Failure to develop BOTE reaction

Action: Consider HIV testing, Immunology referral, Full immunodeficiency workup

Differential Features

ConditionDistinguishing from Molluscum
Warts (Verruca)Rough, Keratotic surface. No central umbilication. Often filiform.
MiliaWhite, Firm. Smaller. No umbilication. Usually face only.
FolliculitisPustular, Hair-centred. May be tender.
Keratosis PilarisRough, Follicular. Arms/Thighs. No umbilication.
Lichen PlanusPolygonal, Flat-topped, Purple. Wickham striae.
Insect BitesRed, Pruritic papules. Central punctum. Clustering different.
Cryptococcosis (HIV)Umbilicated but immunocompromised. Systemic symptoms.
Histoplasmosis (HIV)Similar disseminated papules in HIV. Systemic illness.

5. Clinical Examination

Overview

PurposeApproach
Confirm DiagnosisIdentify characteristic umbilicated papules
Assess SeverityCount and map lesions
Identify ComplicationsSecondary infection, Molluscum dermatitis
Exclude Red FlagsGiant/Extensive (Immunodeficiency), Atypical features
Plan ManagementWatchful waiting vs Treatment indicated

Structured Approach

Step 1: General Inspection

ElementWhat to Look For
General HealthChild appears well (Systemically well)
Skin OverviewDistribution of lesions, Number
Associated Skin ConditionsAtopic dermatitis (Predisposes), Other infections
ScarringPrevious lesions or treatments
Signs of ScratchingLinear marks, Excoriations

Step 2: Lesion Characterisation

FeatureExpected Finding in MolluscumRed Flag
ShapeDome-shaped, HemisphericalIrregular = Consider other diagnosis
Size1-5mm (Up to 10mm)Greater than 15mm = Giant molluscum
ColourFlesh, Pink, Pearly, WhiteVery red = Infection or BOTE
SurfaceSmooth, Shiny, WaxyRough = Consider wart
UmbilicationCentral dimple presentAbsent rare, Use magnification
NumberVariable (1 to hundreds)Greater than 50-100 = Consider immunodeficiency
GroupingMay cluster, Satellite lesionsWidespread = Screen for immune issues

Step 3: Distribution Mapping

SiteTick if InvolvedNumberNotes
Face☐
Eyelids☐Ophthalmology referral if symptomatic
Trunk☐
Axillae☐
Arms☐
Legs☐
Genital/Perineal☐Note if child or adult
Other☐

Step 4: Assessment of Complications

ComplicationSigns to Look For
BOTE SignRed, Swollen, Tender lesions (Good sign = Resolution)
Secondary InfectionSpreading erythema, Warmth, Pustules, Crusting, Pus
Molluscum DermatitisEczematous changes around lesions (Not infection)
ScarringFrom previous treatment or infection

Step 5: Examination of Surrounding Skin

FeatureFindingSignificance
EczemaDry, Scaly, Erythematous patchesAssociated condition. Predisposes. Treat.
ExcoriationsScratch marksAutoinoculation risk. Counsel on scratching.
Pigment ChangesHypo/HyperpigmentationPost-inflammatory. Usually temporary.

Dermoscopy Findings

FeatureDescriptionSignificance
Central White-Yellow StructureAmorphous, HomogeneousCore of molluscum (Virus-laden cells)
Crown/Clover Leaf VesselsPeripheral radiating vesselsCharacteristic pattern
Polylobular PatternMultiple lobulesSeen in established lesions
OrificeCentral openingMay express core

Lesion Expression/Testing

TestTechniqueExpected Finding
Gentle SqueezeApply lateral pressure to lesionWhite, Cheesy, Waxy core may be expressed
Core ExaminationExamine expressed materialContains molluscum bodies
NoteThis is diagnostic but not necessaryClinical diagnosis usually sufficient

Other Examination Components

ElementWhat to ExamineFindings in Uncomplicated MC
Lymph NodesRegional lymphadenopathyAbsent (Unless secondary infection)
Eyes (If Eyelid Lesions)Conjunctival injection, DischargeMay have chronic follicular conjunctivitis
General ExaminationSigns of immunodeficiencyNormal in typical cases

Documentation

Record the Following:

ItemExample Documentation
Number"Approximately 15-20 lesions"
Size Range"2-5mm in diameter"
Distribution"Predominantly trunk and upper limbs"
Morphology"Dome-shaped, Umbilicated papules"
Complications"No signs of BOTE or secondary infection"
Associated Conditions"Background atopic dermatitis noted on flexures"
Diagnosis"Clinical diagnosis: Molluscum contagiosum"

Special Tests Summary

TestTechniquePositive FindingSignificance
DermoscopyExamine with dermatoscopeWhite-yellow central structure, Crown vesselsConfirms diagnosis
Expression of CoreGentle squeeze or curettageWhite cheesy materialCharacteristic
Wood's LampUV examinationNot specificExclude tinea
BiopsyRarely neededHenderson-Patterson bodiesIf diagnosis uncertain

6. Investigations

Diagnosis is Clinical

Investigations are NOT usually required. Diagnosis is based on characteristic clinical appearance. The presence of dome-shaped, umbilicated papules is sufficient for diagnosis in most cases.

Diagnostic Certainty:

PresentationInvestigations Needed
Typical appearance (Umbilicated papules)None required
Atypical featuresConsider dermoscopy first
Still uncertainSkin biopsy for histology
Giant/ExtensiveHIV test if risk factors

When to Investigate

InvestigationIndicationExpected Finding
DermoscopyConfirm diagnosis, Atypical lesionsCentral white structure, Crown vessels
Skin BiopsyAtypical appearance, Diagnostic uncertaintyHenderson-Patterson bodies
HIV TestExtensive/Giant molluscum, Adult with genital lesionsRule out immunodeficiency
STI ScreenAdult genital molluscumComprehensive screen
Full Blood CountIf immunodeficiency suspectedLymphopenia, Other abnormalities
ImmunoglobulinsIf primary immunodeficiency suspectedLow levels

Histopathology (If Performed)

FindingDescriptionSignificance
Henderson-Patterson BodiesLarge eosinophilic intracytoplasmic inclusionsPathognomonic
Molluscum BodiesSame as above – Viral inclusion bodiesDiagnostic
Lobulated Epidermal HyperplasiaEpidermis extends into dermis in lobulesCharacteristic architecture
Central CraterOpens to surfaceContains keratinised debris
Minimal InflammationUnless BOTE phaseImmune evasion

Differential Diagnosis - Detailed

ConditionKey FeaturesHow to Distinguish
Warts (Verruca Vulgaris)Rough, Keratotic surfaceNo umbilication. Rough, Not smooth. Black dots.
MiliaWhite, Firm keratin cystsSmaller. No umbilication. Face. No central core.
FolliculitisHair-centred pustulesPustular. Tender. Hair-centred.
Keratosis PilarisRough, Follicular papulesArms/Thighs. Plugged follicles. No umbilication.
Lichen PlanusPolygonal, Flat-topped, PurpleWickham striae. Different morphology.
Cryptococcosis (HIV)Umbilicated papulesImmunocompromised. Systemic symptoms. Culture.
Histoplasmosis (HIV)Disseminated papulesSystemic illness. Immunocompromised.
Insect BitesPruritic papulesCentral punctum. Different pattern. Clustering.
Basal Cell CarcinomaPearly papule (Adults)Adults only. Single lesion. Rolled edge. Telangiectasia.

7. Management

Management Algorithm

Molluscum Contagiosum Management Algorithm

Key Principles

PrincipleDetails
Watchful Waiting is First-LineSelf-limiting condition. Explain natural history.
Treatment Does Not Always Shorten CourseEvidence is mixed. May just treat visible lesions.
Treatment Has RisksPain, Scarring, Psychological trauma in children
Avoid Over-TreatmentLesions will resolve. Harm may outweigh benefit.
Treat ComorbiditiesEczema, Secondary infection if present
Special PopulationsImmunocompromised need active treatment

First-Line: Watchful Waiting (Preferred)

Strong Rationale:

  • Self-limiting in immunocompetent children
  • Resolves within 6-18 months (Up to 4 years in some cases)
  • Treatment is often painful for children
  • Treatment may cause scarring (Permanent harm for temporary condition)
  • Treatment does not significantly shorten course
  • No evidence of reduced transmission with treatment
  • Cochrane review: No treatment clearly better than waiting
  • BOTE sign (Inflammation around lesions) indicates resolution is imminent

Parental Counseling Points:

TopicWhat to Say
Nature of Condition"This is a very common, Harmless viral skin infection. Like most childhood viruses, It will go away on its own."
Duration"It usually clears within 6-18 months, Sometimes longer. The immune system eventually fights it off."
The 'Red, Angry' Stage"If the spots become red and inflamed, This is actually good news – it means they're about to go away. We call this the 'beginning of the end'."
Treatment"Treatment options exist but are often painful and may leave scars. Since the spots will go anyway, We usually recommend leaving them alone."
Contagion"It can spread by touching. Try not to let your child scratch them. Not sharing towels helps reduce spread at home."
School/Swimming"No need to keep off school. Covering spots in the pool is optional – There's no strong evidence pools spread it."
When to Return"Come back if spots look infected (Red, Oozing pus), If they're near the eyes and causing problems, Or if you're worried."

Practical Advice for Parents:

AdviceExplanation
Don't Pick or ScratchThis spreads the spots to new areas (Autoinoculation)
Keep Nails ShortReduces spread if scratching occurs
Separate TowelsReduce household transmission risk
Don't Share BathsClose contact in water may spread
Emollients/MoisturiserKeep skin hydrated, Especially if eczema
No School ExclusionNot required by guidelines
Covering in PoolOptional. Reduces anxiey. Waterproof plaster/Rash guard.
Watch for BOTEInflammation means resolution is near
Watch for InfectionSpreading redness, Pus, Warmth → See doctor

Indications for Active Treatment

IndicationReasonTreatment Choice
Parental/Patient RequestCosmetic concern, Psychological distressDiscuss risks. Proceed if informed consent.
Prevent AutoinoculationSpreading rapidly despite adviceTreat visible lesions. Address scratching.
Symptomatic LesionsItchy, Causing distressMay reduce itch with treatment.
Eyelid/Periocular LesionsRisk of conjunctivitis, KeratitisCareful treatment. Ophthalmology if needed.
ImmunocompromisedWon't resolve spontaneouslyActive treatment required.
Genital Lesions (Adults)STI context, Reduce transmissionTreat to reduce spread. STI screen.
Secondary InfectionBacterial superinfectionTreat infection + Consider lesion treatment
About to Heal (BOTE)Already resolvingNO treatment needed. Reassure.

Treatment Options - Detailed

Physical Destruction Methods:

MethodTechniqueEffectivenessPainScarring RiskNotes
Cryotherapy (Liquid Nitrogen)Spray or cotton bud. 5-10 seconds per lesion. -196°C.High (70-80%)Moderate-HighModerateMay need repeat sessions. Hypopigmentation risk.
CurettageCurette or sharp spoon scrapes off lesionHigh (80-90%)Moderate (Use EMLA)Low-ModerateEMLA cream 60 min before. Quick. May bleed.
Pricking/ExpressionPierce centre with needle, Express cheesy coreModerate-HighLow-ModerateLowTechnique-dependent. Risk of spread.
Laser (Pulsed Dye)Vascular laser targets lesionHighLow (With anaesthesia)LowExpensive. Not widely available.

Cryotherapy – Detailed Protocol:

StepDetails
PreparationEMLA cream optional (Not always helpful for cryo). Position child. Distraction techniques.
ApplicationLiquid nitrogen via spray or cotton-tipped applicator. Apply until white freeze extends 1-2mm beyond lesion.
Duration5-10 seconds per lesion
Post-ProcedureMild stinging/burning. Blister may form. Lesion crusts and falls off in 1-2 weeks.
RepeatReview at 2-4 weeks. Repeat if needed.
Side EffectsPain, Blistering, Temporary hypopigmentation, Scarring rare

Curettage – Detailed Protocol:

StepDetails
PreparationApply EMLA cream under occlusion 60 minutes before. Explain to child.
TechniqueUse curette or sharp spoon. Scoop/scrape lesion off skin surface. Applies to base.
HaemostasisBrief pressure. Cautery not usually needed.
Post-ProcedureSimple dressing. Clean wound. May have small wound that heals in 1-2 weeks.
Side EffectsMinor bleeding, Pain if EMLA inadequate, Small scar possible

Topical Treatments - Detailed:

AgentMechanismProtocolEffectivenessSide Effects
Potassium Hydroxide (KOH) 5-10%Caustic destructionApply to lesion 1-2x daily with cotton bud. Avoid normal skin. Continue until lesion inflamed.Moderate-High (60-70%)Irritation, Burns if spread, Stinging
Imiquimod 5% CreamImmune modulator (TLR7 agonist)Apply 3x/week at night. Wash off in morning. 4-16 weeks.Variable (40-60%)Erythema, Erosion, Flu-like symptoms, Off-label, Expensive
Podophyllotoxin 0.5%Cytotoxic (Mitotic inhibitor)Apply 2x/day for 3 days, Rest 4 days. Repeat weekly x4.ModerateIrritation. Genital MC in adults. Not children.
Salicylic AcidKeratolyticDaily application. Cover with plaster.Low-ModerateIrritation. Limited evidence.
Tretinoin 0.025-0.05%Retinoid (Keratolytic)Nightly applicationLowIrritation. Limited evidence.
Cantharidin 0.7%Vesicant (Blister agent)Applied in clinic. Cover. Wash off after 4-6 hours.High (70-80%)Blistering (Expected). Not widely available.
Silver NitrateCausticApply to lesionModerateStaining, Burns
Hydrogen Peroxide (Stabilised)Oxidative destructionApplied dailyVariableLimited evidence

Treatment Comparison:

TreatmentEffectivenessPainScarringAccessibilityCochrane Evidence
Watchful WaitingNatural resolutionNoneNoneN/ASupported
CryotherapyHighHighModerateGoodLow quality evidence
CurettageHighModerateLowGoodLow quality evidence
KOH TopicalModerate-HighLow-ModerateLowVariableModerate evidence
ImiquimodVariableLowLowGood (Prescription)Mixed results
CantharidinHighLow (Blisters later)LowPoor (Availability)Low quality

Treatment for Molluscum Dermatitis

FeatureManagement
What it isEczematous reaction around molluscum lesions. Immune response. Not infection.
SymptomsItch, Erythema, Scaling around lesions
TreatmentEmollients (Generous application). Mild topical corticosteroid (Hydrocortisone 1%) for 5-7 days.
PrognosisResolves as molluscum resolves. May indicate BOTE.

Management in Immunocompromised

PrincipleDetails
Disease BehaviourExtensive, Giant, Recalcitrant, May not spontaneously resolve
First StepOptimise underlying condition. In HIV: Start/Optimise ART → Lesions may resolve with immune reconstitution
Active TreatmentRequired. Aggressive approach. Physical methods + Topicals. Multiple sessions.
ImiquimodMay be helpful (Immune activation)
CidofovirTopical or IV. Severe, Refractory cases. Specialist use. Nephrotoxic.
ReferralDermatology, Immunology, ID specialist

Follow-Up

ScenarioFollow-Up
Watchful WaitingReview if concerned, Infected, Or after 12-18 months if not resolving
After TreatmentReview at 2-4 weeks for repeat treatment if needed
ImmunocompromisedRegular specialist follow-up

Referral Criteria

IndicationReferral Target
Extensive/Giant MolluscumDermatology, Consider HIV testing
ImmunocompromisedDermatology + Immunology
Eyelid Lesions Causing SymptomsOphthalmology (If conjunctivitis/keratitis)
Uncertain DiagnosisDermatology (Biopsy if needed)
Treatment-ResistantDermatology for specialist options

8. Complications

Overview

CategoryExamplesFrequency
Complications of DiseaseSpread, Infection, Dermatitis, Ocular involvementCommon
Complications of TreatmentScarring, Pain, Pigment changesVariable by treatment
PsychologicalAnxiety, Embarrassment, School avoidanceOccasional

Complications of Disease - Detailed

Autoinoculation (Self-Spreading):

AspectDetails
FrequencyVery Common
MechanismScratching introduces virus to new sites
Risk FactorsItchy lesions, Eczema, Young children who scratch
PreventionKeep nails short, Discourage scratching, Treat itch
OutcomeMay significantly increase lesion count

Secondary Bacterial Infection:

AspectDetails
Frequency10-20% of cases
Causative OrganismUsually Staphylococcus aureus
Clinical FeaturesSpreading erythema, Warmth, Tenderness, Pustules, Crusting
Differentiate from BOTEBOTE = Localised inflammation. Infection = Spreading, Pus.
TreatmentTopical antibiotics (Fusidic acid). Oral antibiotics if extensive (Flucloxacillin).
PreventionAvoid scratching, Good hygiene

Molluscum Dermatitis:

AspectDetails
Frequency10-30%
What it isEczematous reaction around molluscum lesions
MechanismImmune response to virus, Not infection
Clinical FeaturesErythema, Scaling, Itch around lesions
TreatmentEmollients (Generous). Mild topical corticosteroid (HC 1%) for 5-7 days.
PrognosisResolves as molluscum resolves. May indicate BOTE.
NoteMay mimic bacterial infection. Check for pus to differentiate.

Eyelid Lesions and Ocular Complications:

ComplicationFrequencyClinical FeaturesManagement
Chronic Follicular ConjunctivitisCommon if eyelid MCRed eye, Gritty feeling, DischargeTreat MC. Ophthalmology if persists.
Corneal InvolvementRareKeratitis, Pannus formationUrgent ophthalmology referral
PtosisRareIf large lesion on lidMay need treatment of lesion

Psychological and Social Complications:

ComplicationFrequencyNotes
Parental AnxietyVery CommonConcern about appearance, Contagion
Child EmbarrassmentOccasionalEspecially if facial or numerous
School IssuesOccasionalPressure for exclusion (Not required)
Social AvoidanceOccasionalAvoiding swimming, Playdates
Self-Esteem IssuesRareIf prolonged or extensive

Scarring (From Disease):

AspectDetails
FrequencyRare if untreated
When it OccursIf secondarily infected, Severely inflamed BOTE, Picked/Traumatised
TypeUsually small, Atrophic scars
PreventionAvoid scratching, Treat infection promptly

Post-Inflammatory Pigment Changes:

TypeFrequencyDurationOutcome
HypopigmentationOccasionalWeeks-MonthsUsually temporary. Repigments.
HyperpigmentationOccasionalWeeks-MonthsUsually fades.

Complications of Treatment - Detailed

TreatmentComplicationsPrevention/Management
CryotherapyPain (Significant in children), Blistering (Expected), Scarring (Occasional), Hypopigmentation (Especially dark skin), Infection (Rare)Use EMLA if tolerated. Warn about blisters. Consider risks vs. benefits.
CurettagePain (If EMLA inadequate), Bleeding (Minor), Scarring (Small risk), Infection (Rare)EMLA cream essential. Haemostasis. Wound care.
KOH TopicalIrritation, Stinging, Chemical burns if on normal skin, HypopigmentationCareful application. Avoid surrounding skin. Stop if severe irritation.
ImiquimodErythema, Erosion, Ulceration, Flu-like symptoms (Rare), ExpensiveUse as directed. May need breaks. Not licensed for MC.
CantharidinBlistering (Expected - Mechanism), Pain from blister, Scarring (Rare)Apply carefully. Warn about blister formation.
PodophyllotoxinIrritation, Ulceration, Not for childrenAdult genital use only.

Complications vs. Watchful Waiting

ApproachPotential Complications
Watchful WaitingAutoinoculation (Spread), Possible secondary infection if scratched, Prolonged duration
Active TreatmentPain (Procedure), Scarring, Pigment changes, Incomplete treatment, Recurrence from missed lesions

Key Point: For most children, The complications of treatment (Especially scarring) outweigh the complications of the disease itself.


9. Prognosis & Outcomes

Natural History - Detailed

PhaseDurationDescription
Incubation2-6 weeks (Up to 6 months)Virus acquired. No visible lesions yet.
Early Active DiseaseWeeks-MonthsNew lesions appearing. May spread via autoinoculation.
Peak DiseaseVariableMaximum number of lesions. Waxing and waning.
BOTE Phase1-4 weeks per lesionLesions become inflamed. Immune recognition.
ResolutionWeeks per lesionIndividual lesions resolve. May have new ones appearing simultaneously.
Complete Clearance6-18 months (Up to 4 years)All lesions gone.
Post-ResolutionWeeks-MonthsAny pigment changes fade. Scarring rare.

Outcomes by Population

PopulationTypical OutcomeNotes
Immunocompetent ChildrenComplete resolution in 6-18 months (90%+)Excellent prognosis
Children with EczemaMay have more lesions, Longer durationUsually still resolves
ImmunocompromisedMay not resolve spontaneously. Extensive.Requires treatment and management of underlying condition.
Adults (Genital)Similar resolutionSTI considerations. Partner notification.

Outcomes with Different Approaches

ApproachOutcomeScarring RiskNotes
Watchful WaitingGreater than 90% complete resolution. Average 12-18 months.Very LowPreferred for most children.
CryotherapyClears treated lesions. May recur.ModerateMay not shorten overall course.
CurettageClears treated lesions.Low-ModerateQuick. May miss some.
KOH Topical60-70% clearance.LowHome treatment option.
ImiquimodVariable (40-60%)LowProlonged course. Off-label.

Recurrence

AspectDetails
True Recurrence RateLess than 5%
Apparent RecurrenceOften new lesions from autoinoculation or incomplete treatment
Post-Treatment RecurrenceMore common if not all lesions treated
ImmunityMost develop immunity. Repeat infections uncommon.

Prognostic Factors - Detailed

Favourable Prognosis:

FactorWhy
ImmunocompetentImmune system will clear virus
Limited Number (Less than 20)Easier for immune system. Less autoinoculation.
BOTE Sign AppearingActive immune clearance
No Underlying EczemaIntact skin barrier. Less scratching.
Single Anatomical SiteLimited spread
Older ChildMay have partial immunity. Less scratching.

Unfavourable Prognosis (Prolonged/Extensive):

FactorWhyManagement
Immunocompromised (HIV, Primary, Iatrogenic)Impaired T-cell immunity. Won't clear spontaneously.Optimise immunity. Active treatment. Specialist.
Atopic DermatitisImpaired skin barrier. More lesions. More autoinoculation.Treat eczema aggressively. Emollients.
Large Number (Greater than 50)More sources for spread. Longer to clear.May consider treatment. Investigate immunodeficiency.
Absence of BOTE ReactionSuggests poor immune recognitionMay need longer.
High ScratchingAutoinoculation. Spread.Address scratching. Short nails. Bandages.
Young Child (Less than 2 years)More scratching. Takes longer.Watchful waiting still appropriate.

Long-Term Outcomes

OutcomeFrequencyNotes
Complete Resolution Without ScarringGreater than 90% (Untreated)Expected in most children
Minor Scarring5-10%More common with treatment or infection
Significant ScarringLess than 2%Usually from repeated traumatic treatments
Permanent ImmunityMostRepeat infection uncommon
Psychological RecoveryExcellentOnce gone, No lasting impact

10. Evidence & Guidelines

Key Guidelines

GuidelineOrganisationKey Recommendations
BAD GuidelinesBritish Association of Dermatologists (2017)Watchful waiting first-line. Treatment options if indicated.
AAD PositionAmerican Academy of DermatologySelf-limiting. Treatment for specific indications.

Evidence Summary

Watchful Waiting vs Treatment (Cochrane 2017)

  • Systematic review
  • Result: No single treatment proven clearly superior to no treatment
  • Most lesions resolve spontaneously within 12-24 months
  • Quality of evidence: Low for most interventions
  • PMID: 28643307

Potassium Hydroxide (Metanalysis)

  • Multiple studies
  • Result: Effective, Comparable to cryotherapy
  • Less painful than cryotherapy when used correctly
  • PMID: Various

Evidence Strength

InterventionLevelNotes
Watchful Waiting2aCochrane supports. First-line.
Cryotherapy2bEffective but painful
Curettage2bEffective. Skilld required.
KOH Topical2aMultiple RCTs support.
Imiquimod2bOff-label. Variable results.

11. Patient/Layperson Explanation

What is Molluscum Contagiosum?

Molluscum contagiosum is a very common and completely harmless viral skin infection that causes small, raised bumps on the skin. It is caused by a virus related to the chickenpox virus family.

Key Points:

  • Extremely common in children aged 1-10 years
  • Completely harmless – causes no internal illness
  • Will go away on its own without treatment
  • Not a sign of anything serious

What Do The Spots Look Like?

FeatureDescription
SizeSmall – usually 2-5mm (about the size of a pencil eraser)
ShapeRound, Dome-shaped bumps
ColourFlesh-coloured, Pinkish, or Pearly white
SurfaceSmooth and shiny
Special FeatureOften have a tiny dimple or dent in the centre (Like a belly button)
NumberCan range from just a few to dozens or more
LocationCan appear anywhere – Face, Arms, Trunk, Legs, Armpits

What They're NOT:

  • Not usually red (Unless healing or infected)
  • Not painful (Unless infected)
  • Not usually itchy (Though surrounding skin may become dry)

How Did My Child Get This?

The virus spreads by:

MethodHow it Happens
Direct TouchSkin-to-skin contact with someone who has the spots
Self-Spreading (Scratching)If your child scratches one spot and then touches another area, They can spread the virus to themselves
Sharing ThingsSharing towels, Clothes, Bath toys with someone who has molluscum
Swimming/BathingPossibly through sharing pool surroundings (Not proven to be from the water itself)

Who is at Risk?

  • Children aged 1-10 (Most common)
  • Children with eczema (Dry skin makes it easier for the virus to spread)
  • Anyone who has close contact with an infected person

Does It Need Treatment?

Usually NO – And Here's Why:

ReasonExplanation
Self-LimitingThe spots WILL go away on their own – Your child's immune system will fight off the virus
DurationUsually within 6-18 months, Sometimes up to 2 years
Treatment Can Be PainfulFreezing, Scraping, Or chemicals can hurt – This is hard for young children
Treatment May ScarThe treatments can leave permanent marks. The spots usually heal without any scarring if left alone.
Treatment Doesn't Speed Up Resolution SignificantlyEvidence shows treatments mainly remove visible spots. The virus may still cause new spots.

When Treatment Might Be Considered:

SituationWhy Treat
Very distressingIf the spots are really bothering your child or the family
Near the eyesIf spots are on the eyelids and causing eye irritation
Spreading rapidlyIf new spots appear frequently despite care
Weak immune systemChildren with immune problems may need treatment
Significant concernAfter understanding the pros and cons, Some families still prefer treatment

The 'Beginning of the End' (BOTE Sign)

This is GOOD NEWS!

[!TIP] If the spots become red, Swollen, And a bit tender – Don't panic!

This is called the "Beginning of the End" or BOTE sign. It means your child's immune system has finally recognised the virus and is fighting it. These inflamed spots will heal and disappear within 1-4 weeks.

This is NOT an infection. It's the body's natural healing response.

How to tell the difference:

BOTE (Normal Healing)Infection (Need to See Doctor)
Spots become red and puffySpreading redness beyond the spot
May be slightly tenderIncreasing pain and tenderness
No pus or dischargeYellow/Green pus or weeping
Child otherwise wellChild unwell, Fever
Spots start shrinkingSpots getting bigger

What Can I Do At Home?

Practical Tips:

ActionWhy It Helps
Don't pick or scratchScratching spreads the virus to new areas
Keep nails shortLess damage if accidental scratching
Separate towelsEach family member should have their own towel
No shared bathsBathe children separately if possible
Use moisturiserEspecially if dry skin or eczema – Healthy skin is more resistant
Cover if swimmingOptional – Waterproof plaster or rash guard for peace of mind
Reassure your childAvoid making them feel embarrassed – It's very common

School and Activities

ActivityGuidance
School/NurseryNO exclusion required. Can attend normally.
SwimmingCan still swim. Consider covering spots.
SportsCan participate. Cover spots if contact sport.
PlaydatesCan socialise. Avoid direct contact with spots.

When to See a Doctor

Routine Appointment:

  • If you want to discuss treatment options
  • If spots are spreading very rapidly
  • If you're unsure about the diagnosis
  • If eczema around spots is difficult to control

See Doctor Sooner if:

  • Spots look infected (Red spreading, Pus, Warmth)
  • Spots near the eyes are causing irritation or discharge
  • Your child has a known immune system problem
  • Spots are causing significant distress

Emergency (Rare):

  • Signs of severe skin infection (Large area of spreading redness, Your child is unwell with fever)

Frequently Asked Questions

Q: How long will these spots last? A: Usually 6-18 months. Sometimes up to 2 years. They will go away eventually.

Q: Will they scar? A: If left alone, They rarely leave scars. Treatment is more likely to cause scarring than the spots themselves.

Q: Are they contagious? A: Yes, The virus can spread by touch. However, Many children are exposed and never get it. It's not highly contagious like chickenpox.

Q: Can my child go to school? A: Yes! There's no need to stay off school or nursery. Guidelines say no exclusion is required.

Q: Can my child go swimming? A: Yes. You can cover the spots with a waterproof plaster or rash guard if you prefer. There's no strong evidence that pools spread the virus.

Q: Should we treat them? A: Usually no. Treatment options exist but are often painful and may scar. Since they go away on their own, We generally recommend waiting.

Q: Why are they spreading? A: Likely from scratching (The virus spreads from one spot to another). Try to discourage scratching and keep nails short.

Q: Is it related to hygiene? A: No! Molluscum is very common in healthy children. It has nothing to do with being clean or dirty.

Q: Can adults get it? A: Yes, But it's less common. In adults, Especially if on the genitals, It may be sexually transmitted.

Q: Will my child be immune after this? A: Generally yes. Most people develop immunity after an infection and don't get it again.

Psychological and Social Support

For Your Child:

  • Reassure them it's very common ("Lots of children get this")
  • Don't make a big deal of the spots
  • Explain they will go away
  • If other children ask, A simple "It's just a skin thing that will go away" is enough

For Parents:

  • It can be frustrating waiting for them to go – This is normal
  • Other parents may worry about contagion – You can explain it's not highly contagious
  • If you feel pressured to keep your child home, Guidelines say this is not necessary

Visual Guide

What to Look For:

StageAppearance
New SpotSmall, Flesh-coloured papule. May not have central dimple yet.
EstablishedClassic dome-shape with central dimple. Shiny.
BOTE (Healing)Red, Swollen, Tender. About to go away.
ResolvingShrinking, Crusting, Disappearing.
HealedMay be slight temporary discolouration. Usually no scar.

Support Resources

ResourceDetails
NHS Websitewww.nhs.uk – Search "Molluscum contagiosum"
BAD Patient Informationwww.bad.org.uk – British Association of Dermatologists
Your GP/Health VisitorFirst point of contact for concerns
DermatologyIf referral needed for complex cases

12. References

Primary Guidelines

  1. Olsen JR, et al. Molluscum contagiosum, Childhood. BMJ Clin Evid. 2015. PMID: 26068792

  2. van der Wouden JC, et al. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev. 2017;5:CD004767. PMID: 28643307

  3. British Association of Dermatologists. Patient Information: Molluscum Contagiosum. BAD. 2017.

Evidence

  1. Forbat E, et al. Molluscum contagiosum: Review and update on management. Pediatr Dermatol. 2017;34(5):504-515. PMID: 28884896

  2. Hanson D, Diven DG. Molluscum contagiosum. Dermatol Online J. 2003;9(2):2. PMID: 12639455

  3. Chen X, et al. Topical treatments for molluscum contagiosum. Cochrane Database Syst Rev. 2013;3:CD010118.

  4. Katz KA. Dermatologists, Imiquimod, and treatment of molluscum contagiosum in children. JAMA Dermatol. 2015;151(2):125-126. PMID: 25354321

Additional References

  1. Brown J, et al. Childhood molluscum contagiosum. Int J Dermatol. 2006;45(2):93-99. PMID: 16445497

  2. Dohil MA, et al. The epidemiology of molluscum contagiosum in children. J Am Acad Dermatol. 2006;54(1):47-54. PMID: 16384754

  3. Shisler JL. Immune evasion strategies of molluscum contagiosum virus. Adv Virus Res. 2015;92:201-252. PMID: 25701888

  4. Silverberg NB. Pediatric molluscum contagiosum: Optimal treatment strategies. Paediatr Drugs. 2003;5(8):505-512. PMID: 12906691

  5. Sladden MJ, Johnston GA. Common skin infections in children. BMJ. 2004;329(7457):95-99. PMID: 15242916

  6. Tyring SK. Molluscum contagiosum: The importance of early diagnosis and treatment. Am J Obstet Gynecol. 2003;189(3 Suppl):S12-16. PMID: 14532897

  7. Leung AKC, et al. Molluscum contagiosum: An update. Recent Pat Inflamm Allergy Drug Discov. 2017;11(1):22-31. PMID: 28477684

  8. Meza-Romero R, et al. Treatment of molluscum contagiosum with potassium hydroxide. Dermatol Ther. 2019;32(2):e12806. PMID: 30652385


13. Examination Focus

High-Yield Facts for Exams

CategoryKey Points
DefinitionBenign, Self-limiting viral infection (MCV, Poxviridae)
Pathognomonic FeatureUmbilicated (Central dimple) dome-shaped papules
HistologyHenderson-Patterson bodies (Molluscum bodies)
Peak Age1-10 years
Duration6-18 months (Up to 4 years)
First-Line ManagementWatchful waiting
BOTE SignBeginning Of The End - Inflammation signals resolution
Red FlagGiant/Extensive molluscum = Consider immunodeficiency

Common Exam Questions

Short Answer Questions:

  1. Clinical Scenario: "A 5-year-old presents with multiple small, Dome-shaped, Umbilicated papules on the trunk. What is the diagnosis and management?"

    • Answer: Molluscum contagiosum. Management: Watchful waiting (Self-limiting). Reassure parents.
  2. Pathognomonic Finding: "What is the characteristic histological finding in molluscum contagiosum?"

    • Answer: Henderson-Patterson bodies (Large eosinophilic intracytoplasmic inclusion bodies).
  3. BOTE Sign: "What is the BOTE sign in molluscum contagiosum?"

    • Answer: Beginning Of The End – Inflammation around lesions indicates immune response and impending resolution.
  4. Red Flag: "When should you be concerned about molluscum contagiosum?"

    • Answer: Giant molluscum (greater than 1cm), Extensive disease, Recalcitrant lesions → Suggests immunodeficiency (e.g., HIV).
  5. Treatment Options: "What are the treatment options for molluscum if intervention is required?"

    • Answer: Cryotherapy, Curettage, Potassium hydroxide topical, Imiquimod.

MCQ-Style Questions:

  1. Best Answer: "A 4-year-old has 15 flesh-coloured papules with central dimples on his arms. Parents ask about treatment. What is the best advice?"

    • A) Prescribe imiquimod
    • B) Arrange curettage under general anaesthetic
    • C) Reassure and advise watchful waiting ✓
    • D) Urgent referral to dermatology
    • E) Prescribe oral aciclovir
  2. Diagnosis: "Which of the following best describes the causative organism?"

    • A) Herpesvirus
    • B) Papillomavirus
    • C) Poxvirus ✓
    • D) Retrovirus
    • E) Adenovirus
  3. Complication: "A child with molluscum develops red, swollen, tender lesions. What is the most likely explanation?"

    • A) Secondary bacterial infection
    • B) Beginning Of The End (BOTE) ✓
    • C) Allergic reaction
    • D) HSV superinfection
    • E) Impetigo

OSCE Stations

Station 1: Clinical Examination

ComponentRequired Content
IntroductionIntroduce self, Confirm patient identity, Explain examination
ConsentObtain consent for skin examination
InspectionDescribe: Dome-shaped papules, Central umbilication, Distribution, Number, Colour
DermoscopyDescribe clover-leaf/Crown vessel pattern if asked
Surrounding SkinComment on molluscum dermatitis if present, Eczema
Red FlagsComment on size (Giant?), Number (Extensive?), Suggest immunodeficiency if applicable
Summary"This child has multiple dome-shaped, umbilicated papules consistent with molluscum contagiosum"

Station 2: History and Counseling

Question AreaKey Points
History TakingDuration, Spread, Treatments tried, Eczema history, Symptoms, School concerns
CounselingExplain diagnosis, Benign nature, Self-limiting (6-18 months), BOTE sign reassurance, Treatment options (Pros and cons), School guidance (No exclusion)

Station 3: Parent Communication

ScenarioApproach
"Parent requests treatment"Acknowledge concern. Explain natural history. Discuss treatment risks (Pain, Scarring). Shared decision if still want treatment.
"Parent worried about contagion"Explain transmission. Not highly contagious. Practical advice (Separate towels). School attendance OK.
"Parent worried about scarring"Reassure: Untreated lesions rarely scar. Treatment more likely to scar.

Viva Points

Opening Statement:

"Molluscum contagiosum is a common, Benign, Self-limiting viral skin infection caused by the Molluscum Contagiosum Virus, A poxvirus. It is characterised by dome-shaped, Umbilicated papules and is most common in children aged 1-10 years. It typically resolves spontaneously within 6-18 months, And therefore watchful waiting is the first-line management."

Key Facts to Mention:

FactDetails
VirusPoxviridae family, MCV-1 most common in children
TransmissionDirect contact, Autoinoculation, Fomites
AppearanceUmbilicated papules – Central dimple is pathognomonic
PrognosisSelf-limiting in immunocompetent (6-18 months)
BOTEInflammation = Resolution imminent
First-LineWatchful waiting
HistologyHenderson-Patterson bodies

Classification to Quote:

  • "MCV has subtypes: MCV-1 (Children) and MCV-2 (Adults, Sexually transmitted)"

Evidence to Cite:

  • "A Cochrane review (2017) found no single treatment clearly superior to watchful waiting in immunocompetent children"
  • "PMID 28643307"

Common Mistakes

What Fails Candidates:

MistakeWhy It's Wrong
❌ Over-treatingRecommending cryotherapy for every child. First-line is watchful waiting.
❌ Not knowing BOTEMissing this high-yield sign that signals resolution
❌ Forgetting Henderson-Patterson bodiesClassic histology finding
❌ Missing immunodeficiency linkExtensive disease warrants HIV testing
❌ Confusing with wartsWarts have rough surface, No umbilication
❌ Saying "treatment shortens disease"Evidence doesn't strongly support this

Dangerous Errors:

  • ⚠️ Missing immunodeficiency in extensive/Giant molluscum
  • ⚠️ Aggressive treatment causing scarring in a self-limiting condition
  • ⚠️ Prescribing aciclovir (Wrong virus family)

Outdated Practices:

  • Routine treatment of all cases – Now watchful waiting preferred
  • School exclusion – Not required

Examiner Follow-Up Questions

QuestionModel Answer
"What if the lesions are on the eyelid?"May cause conjunctival irritation. Consider ophthalmology referral if symptomatic. Treatment may be indicated.
"What is molluscum dermatitis?"Eczematous reaction around lesions. Not infection. Immune response. Treat with emollients and HC 1%.
"Can children go to school?"Yes. No exclusion required. Cover lesions if swimming (Optional).
"What if an adult presents with genital molluscum?"Likely sexually transmitted. Consider STI screening. Partner notification.
"What is the evidence for treatment?"Cochrane 2017: No single treatment clearly superior to watchful waiting. Low quality evidence for most.
"How would you counsel a parent who insists on treatment?"Explain risks and benefits. If they still want treatment, Discuss options (KOH, Curettage). Shared decision. Document discussion.
"What is the incubation period?"2-6 weeks, Can be up to 6 months.
"What is the difference between MCV-1 and MCV-2?"MCV-1: Children, Non-sexual. MCV-2: Adults, Often sexually transmitted.

Differential Diagnosis Discussion

If Asked...Answer
"What else could this be?"Warts (Rough surface), Milia (No umbilication), Folliculitis (Pustular), Insect bites, Keratosis pilaris
"How would you exclude warts?"Warts: Rough, Keratotic, No central dimple. May have black dots (Thrombosed capillaries).
"What if immunocompromised?"Consider Cryptococcosis, Histoplasmosis (Systemic symptoms in HIV). Biopsy if uncertain.

Last Reviewed: 2025-12-25 | MedVellum Editorial Team


Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists and current guidelines.

Last updated: 2025-12-25

At a Glance

EvidenceHigh
Last Updated2025-12-25

Red Flags

  • Extensive Lesions in Immunocompromised
  • Giant Molluscum (Suggests HIV)
  • Secondary Bacterial Infection

Clinical Pearls

  • **"Umbilicated Papules with Central Dimple"**: Pathognomonic appearance.
  • **"Leave Them Alone"**: Self-limiting in immunocompetent. Watch and wait is first-line.
  • **"BOTE Sign"**: Beginning Of The End – Inflammatory reaction around lesions signals immune clearance.
  • **"Extensive or Giant Molluscum = Consider Immunodeficiency"**: Screen for HIV if appropriate.
  • **"Molluscum Dermatitis"**: Eczematous reaction around lesions – Treat with emollients/Mild TCS.

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines